Interestingly, unlike the classical markers of inflammation, CRP, ESR, and SAA, S100A12 was significantly elevated in clinically unaffected homozygous MEFV gene mutation carriers, supporting the ongoing subclinical inflammation in FMF. This evidence concerns the gene SAA1 and familial Mediterranean fever.